KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

FinVolution Group (FINV) Research & Development: 2018-2025

Historic Research & Development for FinVolution Group (FINV) over the last 8 years, with Sep 2025 value amounting to -$19.5 million.

  • FinVolution Group's Research & Development fell 4.83% to -$19.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$72.2 million, marking a year-over-year decrease of 3.58%. This contributed to the annual value of -$68.1 million for FY2024, which is 194.56% down from last year.
  • As of Q3 2025, FinVolution Group's Research & Development stood at -$19.5 million, which was down 8.47% from -$18.0 million recorded in Q2 2025.
  • FinVolution Group's 5-year Research & Development high stood at -$14.3 million for Q1 2021, and its period low was -$20.7 million during Q4 2021.
  • Over the past 3 years, FinVolution Group's median Research & Development value was -$18.0 million (recorded in 2023), while the average stood at -$17.8 million.
  • Data for FinVolution Group's Research & Development shows a peak YoY increase of 83.65% (in 2021) and a maximum YoY decrease of 106.46% (in 2021) over the last 5 years.
  • FinVolution Group's Research & Development (Quarterly) stood at -$20.7 million in 2021, then climbed by 3.68% to -$19.9 million in 2022, then increased by 9.86% to -$18.0 million in 2023, then grew by 3.76% to -$17.3 million in 2024, then dropped by 4.83% to -$19.5 million in 2025.
  • Its Research & Development stands at -$19.5 million for Q3 2025, versus -$18.0 million for Q2 2025 and -$17.4 million for Q1 2025.